glp-1 pill news What the Wegovy means for patients and clinicians Lilly's new GLP-1 pill is
Description
How accurate are at-home drug tests
Dual GLP-1 and GIP agonist tirzepatide exerted neuroprotective action in a Parkinson's disease rat model
Wegovy was also recently approved to treat noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis in adults
The majority of the studies (6 out of 8, 75%) specifically addressed GDM
doi: 10.1371/journal.pone.0270143
